Literature DB >> 25128172

Hyperbilirubinemia modulates myocardial function, aortic ejection, and ischemic stress resistance in the Gunn rat.

Bhavisha Bakrania1, Eugene F Du Toit1, Kevin J Ashton2, Can J Kiessling2, Karl-Heinz Wagner3, John P Headrick1, Andrew C Bulmer4.   

Abstract

Mildly elevated circulating unconjugated bilirubin (UCB) is associated with protection against hypertension and ischemic heart disease. We assessed whether endogenously elevated bilirubin in Gunn rats modifies cardiovascular function and resistance to ischemic insult. Hearts were assessed ex vivo (Langendorff perfusion) and in vivo (Millar catheterization and echocardiography), and left ventricular myocardial gene expression was measured via quantitative real-time PCR. Ex vivo analysis revealed reduced intrinsic contractility in the Gunn myocardium (+dP/dt: 1,976 ± 622 vs. 2,907 ± 334 mmHg/s, P < 0.01; -dP/dt: -1,435 ± 372 vs. -2,234 ± 478 mmHg/s, P < 0.01), which correlated positively with myocardial UCB concentration (P < 0.05). In vivo analyses showed no changes in left ventricular contractile parameters and ejection (fractional shortening and ejection fraction). However, Gunn rats exhibited reductions in the rate of aortic pressure development (3,008 ± 461 vs. 4,452 ± 644 mmHg/s, P < 0.02), mean aortic velocity (439 ± 64 vs. 644 ± 62 mm/s, P < 0.01), and aortic volume time integral pressure gradient (2.32 ± 0.65 vs. 5.72 ± 0.74 mmHg, P < 0.01), in association with significant aortic dilatation (12-24% increase in aortic diameter, P < 0.05). Ex vivo Gunn hearts exhibited improved ventricular function after 35 min of ischemia and 90 min of reperfusion (63 ± 14 vs. 35 ± 12%, P < 0.01). These effects were accompanied by increased glutathione peroxidase and reduced superoxide dismutase and phospholamban gene expression in Gunn rat myocardium (P < 0.05). These data collectively indicate that hyperbilirubinemia in Gunn rats 1) reduces intrinsic cardiac contractility, which is compensated for in vivo; 2) induces aortic dilatation, which may beneficially influence aortic ejection velocities and pressures; and 3) may improve myocardial stress resistance in association with beneficial transcriptional changes. These effects may contribute to protection from cardiovascular disease with elevated bilirubin.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  Gilbert's syndrome; bilirubin; ischemia-reperfusion; ischemic heart disease; myocardium; vascular function

Mesh:

Substances:

Year:  2014        PMID: 25128172     DOI: 10.1152/ajpheart.00001.2014

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

1.  Bilirubin protects the ageing heart.

Authors:  S O Adeosun; D E Stec
Journal:  Acta Physiol (Oxf)       Date:  2017-03-30       Impact factor: 6.311

Review 2.  Bilirubin Safeguards Cardiorenal and Metabolic Diseases: a Protective Role in Health.

Authors:  Terry D Hinds; David E Stec
Journal:  Curr Hypertens Rep       Date:  2019-10-10       Impact factor: 5.369

Review 3.  Bilirubin, a Cardiometabolic Signaling Molecule.

Authors:  Terry D Hinds; David E Stec
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

Review 4.  Heme Oxygenase-1 Upregulation: A Novel Approach in the Treatment of Cardiovascular Disease.

Authors:  Lars Bellner; Nachum B Lebovics; Rochelle Rubinstein; Yosef D Buchen; Emilia Sinatra; Giuseppe Sinatra; Nader G Abraham; John A McClung; Ellen A Thompson
Journal:  Antioxid Redox Signal       Date:  2020-02-10       Impact factor: 8.401

5.  Impairment of enzymatic antioxidant defenses is associated with bilirubin-induced neuronal cell death in the cerebellum of Ugt1 KO mice.

Authors:  G Bortolussi; E Codarin; G Antoniali; C Vascotto; S Vodret; S Arena; L Cesaratto; A Scaloni; G Tell; A F Muro
Journal:  Cell Death Dis       Date:  2015-05-07       Impact factor: 8.469

6.  Bilirubin Decreases Macrophage Cholesterol Efflux and ATP-Binding Cassette Transporter A1 Protein Expression.

Authors:  Dongdong Wang; Anela Tosevska; Elke H Heiß; Angela Ladurner; Christine Mölzer; Marlies Wallner; Andrew Bulmer; Karl-Heinz Wagner; Verena M Dirsch; Atanas G Atanasov
Journal:  J Am Heart Assoc       Date:  2017-04-28       Impact factor: 5.501

7.  Cardioprotective Heme Oxygenase-1-PGC1α Signaling in Epicardial Fat Attenuates Cardiovascular Risk in Humans as in Obese Mice.

Authors:  Shailendra P Singh; John A McClung; Ellen Thompson; Yosef Glick; Menachem Greenberg; Giancarlo Acosta-Baez; Basel Edris; Joseph I Shapiro; Nader G Abraham
Journal:  Obesity (Silver Spring)       Date:  2019-08-23       Impact factor: 5.002

8.  Bilirubin Nanoparticles Protect Against Cardiac Ischemia/Reperfusion Injury in Mice.

Authors:  Wen Ai; Soochan Bae; Qingen Ke; Shi Su; Ruijian Li; Yanwei Chen; Dohyun Yoo; Eesac Lee; Sangyong Jon; Peter M Kang
Journal:  J Am Heart Assoc       Date:  2021-10-08       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.